Cardiovascular Events, Health Complications, and Death Rates in Individuals with and without HIV in Two Hospitals in Northern Uganda - Scorecard - MDSpire
Advertisement
Cardiovascular Events, Health Complications, and Death Rates in Individuals with and without HIV in Two Hospitals in Northern Uganda
Clinical Scorecard: Cardiovascular Events, Health Complications, and Death Rates in Individuals with and without HIV in Two Hospitals in Northern Uganda
At a Glance
Category
Detail
Condition
Cardiovascular disease (CVD) and major adverse cardiovascular events (MACE) in people living with and without HIV
Key Mechanisms
Direct HIV viral effects, opportunistic infections, persistent inflammation, endothelial injury, extracellular-vesicle-mediated vascular damage, premature aging, atherosclerosis, and traditional risk factors like hypertension and smoking
Target Population
Adult patients (≥18 years) hospitalized with cardiovascular disease with known HIV status in Northern Uganda
Care Setting
Hospital inpatient care at regional referral hospitals in sub-Saharan Africa
Key Highlights
People living with HIV (PLWH) have a higher risk of major adverse cardiovascular events including heart failure, acute myocardial infarction, and stroke.
HIV infection may modify the risk of in-hospital mortality among patients hospitalized with major adverse cardiovascular events.
There is a significant research gap in cardiovascular disease outcomes and mortality among PLWH in sub-Saharan Africa despite high disease burden.
Guideline-Based Recommendations
Diagnosis
Confirm HIV status in all patients hospitalized with cardiovascular disease.
Use the three-point definition of MACE: heart failure, acute myocardial infarction, and stroke.
Management
Implement prevention strategies targeting both HIV infection and traditional cardiovascular risk factors such as hypertension and smoking.
Consider the impact of prolonged antiretroviral therapy on cardiovascular risk.
Monitoring & Follow-up
Monitor cardiovascular outcomes and mortality rates in PLWH hospitalized with MACE.
Assess for effect modification by HIV status on mortality risk during hospitalization.
Risks
Increased risk of cardiovascular morbidity and mortality in PLWH compared to HIV-negative individuals.
Persistent inflammation and endothelial injury contribute to elevated cardiovascular risk in HIV.
Disparities in cardiovascular outcomes persist in resource-limited settings despite ART availability.
Patient & Prescribing Data
Adults hospitalized with cardiovascular disease and known HIV status in Northern Uganda
Antiretroviral therapy reduces HIV-related morbidity but does not eliminate increased cardiovascular risk; combined management of HIV and cardiovascular risk factors is essential.
Clinical Best Practices
Screen all cardiovascular patients for HIV to identify high-risk individuals.
Integrate cardiovascular risk factor management with HIV care, especially controlling hypertension and smoking cessation.
Prioritize research and data collection on cardiovascular outcomes in PLWH in sub-Saharan Africa to inform tailored prevention and treatment strategies.
by Mark Okwir, Emmy Okello, Abigail Link, Immaculate Akullo, Pancras Odongo, Bernard Omech, Francis Kiweewa, Yu Liu, David Meya, Paul R. Bohjanen, Robert C. Block
Population-based cohort shows higher rates of cardiac arrhythmias and coronary artery disease following nonhospitalized infections, with sex-specific differences.
